Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Your own tooth could help save your jawbone after extraction

NCT ID NCT06027528

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to preserve the jawbone after a tooth is pulled. Researchers took the extracted tooth, ground it into tiny particles, and mixed it with the patient's own fibrin glue (a natural blood-clotting substance) before placing it back into the socket. They compared this to using the tooth particles alone. The goal was to see which method better maintained the width and height of the jawbone over six months. The trial involved 20 healthy, non-smoking adults with damaged teeth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dentin graft with or without autologous fibrin glue
What this could lead to
If it works, this could improve bone healing after tooth extraction, making future dental implants more successful.
What could go wrong
This is a very small, early study with only 20 participants, so results may not apply to everyone. The procedure is also limited to people with healthy gums and no major health issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Sep 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Systemically healthy patients ≥18 years old * Nonsmoker * Teeth with root fracture, teeth with failed endodontic therapy or advanced caries * Intact extraction socket with no dehiscence or fenestration. Exclusion Criteria: * Patients with systemic diseases. * Patients with dehiscence or fenestrations * Patients with presence or history of osteonecrosis of the jaws, with use of bisphosphonates, exposure to head and neck radiation, chemotherapy. * Patients with large distinct pre-apical pathology * Smokers of more than 10 cigarettes a day or equivalent to cigarettes * Breastfeeding or pregnant women * Patients without availability to attend follow-up visits or patients rejecting to sign the informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Unrestorable dentition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cairo University

    Cairo, 12012, Egypt